Sandra D. Comer

11.0k total citations · 1 hit paper
195 papers, 7.9k citations indexed

About

Sandra D. Comer is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sandra D. Comer has authored 195 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Public Health, Environmental and Occupational Health, 62 papers in Pharmacology and 61 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sandra D. Comer's work include Opioid Use Disorder Treatment (90 papers), Neurotransmitter Receptor Influence on Behavior (49 papers) and Substance Abuse Treatment and Outcomes (42 papers). Sandra D. Comer is often cited by papers focused on Opioid Use Disorder Treatment (90 papers), Neurotransmitter Receptor Influence on Behavior (49 papers) and Substance Abuse Treatment and Outcomes (42 papers). Sandra D. Comer collaborates with scholars based in United States, United Kingdom and Australia. Sandra D. Comer's co-authors include Jermaine D. Jones, Richard W. Foltin, Margaret Haney, Marian W. Fischman, Maria A. Sullivan, Suzanne K. Vosburg, Shanthi Mogali, Eric D. Collins, Amie S. Ward and Carl L. Hart and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sandra D. Comer

188 papers receiving 7.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polydrug abuse: A review of opioid and benzodiazepine combination use

2012 522 citations Jermaine D. Jones, Sandra D. Comer et al. Drug and Alcohol Dependence profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sandra D. Comer	2.9k	2.7k	2.7k	1.9k	1.1k	195	7.9k
Eric C. Strain	1.5k 0.5×	4.1k 1.5×	2.2k 0.8×	2.9k 1.5×	941 0.9×	199	8.7k
Herbert D. Kleber	3.2k 1.1×	2.8k 1.0×	1.9k 0.7×	4.0k 2.1×	657 0.6×	192	10.0k
Donald R. Jasinski	2.7k 0.9×	2.0k 0.7×	1.5k 0.6×	1000 0.5×	1.2k 1.1×	106	7.0k
Kyle M. Kampman	3.0k 1.0×	1.4k 0.5×	1.2k 0.5×	2.4k 1.3×	540 0.5×	143	7.0k
Frances R. Levin	2.5k 0.9×	1.6k 0.6×	2.7k 1.0×	2.5k 1.3×	389 0.4×	272	8.7k
Ashwin A. Patkar	1.2k 0.4×	1.1k 0.4×	1.8k 0.7×	1.1k 0.6×	933 0.9×	282	7.2k
Jerome H. Jaffe	1.9k 0.7×	1.9k 0.7×	839 0.3×	2.1k 1.1×	475 0.5×	166	6.0k
Charles R. Schuster	6.7k 2.3×	1.1k 0.4×	1.6k 0.6×	1.6k 0.8×	912 0.9×	177	10.5k
Mehmet Sofuoglu	3.0k 1.0×	929 0.3×	1.2k 0.5×	1.2k 0.6×	1.9k 1.8×	204	7.6k
Ira A. Liebson	1.4k 0.5×	1.9k 0.7×	932 0.4×	1.7k 0.9×	597 0.6×	118	4.9k

Countries citing papers authored by Sandra D. Comer

Since Specialization

Citations

This map shows the geographic impact of Sandra D. Comer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra D. Comer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra D. Comer more than expected).

Fields of papers citing papers by Sandra D. Comer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra D. Comer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra D. Comer. The network helps show where Sandra D. Comer may publish in the future.

Co-authorship network of co-authors of Sandra D. Comer

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra D. Comer. A scholar is included among the top collaborators of Sandra D. Comer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra D. Comer. Sandra D. Comer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Comer, Sandra D., et al.. (2025). Nonpharmacological and pharmacological influences on opioid effects: A review of clinical research findings. Journal of Pharmacology and Experimental Therapeutics. 392(10). 103709–103709.

Nielsen, Suzanne, João Pedro Silva, Jermaine D. Jones, et al.. (2025). Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids. Drug and Alcohol Review. 45(1). e70040–e70040.

Comer, Sandra D., et al.. (2024). Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 Agonist. Journal of Pharmacology and Experimental Therapeutics. 391(2). 272–278.

Walsh, Sharon, et al.. (2024). Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology. 49(6). 1050–1057. 3 indexed citations

McGinty, Jacqueline F., Victoria Arango, Kathleen T. Brady, et al.. (2024). Will the promise of translational neuropsychopharmacology research ever deliver? The lion’s roar; the kitten’s purr. PubMed. 2(1). 4–4.

Jones, Jermaine D., et al.. (2023). Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert Opinion on Investigational Drugs. 32(1). 77–87. 9 indexed citations

Jones, Jermaine D., et al.. (2022). Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance. Addiction. 118(4). 719–726. 8 indexed citations

Castillo, Felipe, Rahul Gupta, Cale Basaraba, et al.. (2022). Preliminary attitudes on medications for opioid use disorders (MOUDs) in Southeastern Switzerland and New York City. Journal of Addictive Diseases. 41(1). 91–97. 1 indexed citations

Arout, Caroline A., Ziva D. Cooper, Stephanie Collins Reed, et al.. (2021). 5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers. Addiction Biology. 26(4). e12993–e12993. 12 indexed citations

10.

Brandt, Laura, Aimee Campbell, Jermaine D. Jones, et al.. (2021). Emotional Reactions of Trained Overdose Responders who use Opioids following Intervention in an Overdose Event. Substance Abuse. 43(1). 581–591. 4 indexed citations

11.

Brandt, Laura, Takuya Yanagida, Aimee Campbell, et al.. (2021). Multi-informant Implementation and Intervention Outcomes of Opioid Overdose Education and Naloxone Distribution in New York City. PubMed. 1(3). 209–222. 3 indexed citations

12.

Neale, Joanne, Adrian Farrugia, Aimee Campbell, et al.. (2021). Understanding preferences for type of take-home naloxone device: international qualitative analysis of the views of people who use opioids. Drugs Education Prevention and Policy. 29(2). 109–120. 11 indexed citations

13.

Jones, Jermaine D., Laura Brandt, Denise A. Hien, et al.. (2021). Factor structure and psychometric properties of the Connor–Davidson resilience scale (CD-RISC) in individuals with opioid use disorder. Drug and Alcohol Dependence. 221. 108632–108632. 18 indexed citations

14.

Winstanley, Erin L., James J. Mahoney, Felipe Castillo, & Sandra D. Comer. (2021). Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review. Drug and Alcohol Dependence. 226. 108838–108838. 26 indexed citations

15.

Brandt, Laura, et al.. (2020). Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction. 116(4). 694–710. 49 indexed citations

16.

Wai, Jonathan, et al.. (2019). Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal. Drug and Alcohol Dependence. 204. 107538–107538. 12 indexed citations

17.

Neale, Joanne, Aimee Campbell, Jermaine D. Jones, et al.. (2018). How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies. Addiction. 114(4). 708–718. 38 indexed citations

18.

Jones, Jermaine D., et al.. (2016). The effects of heroin administration and drug cues on impulsivity. Journal of Clinical and Experimental Neuropsychology. 38(6). 709–720. 17 indexed citations

19.

MacDonald, Matthew, Darrick T. Balu, Yi Zuo, Sandra D. Comer, & Jordan F. Karp. (2015). Panels, Mini-Panels and Study Groups. Neuropsychopharmacology. 40(S1). S1–S105. 3 indexed citations

20.

Porreca, Frank, Henry I. Mosberg, K J Chang, et al.. (1993). Pharmacology of multiple opioid delta receptors. 430–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact